Home › NDC Lookup › RxCUI directory › RxCUI 1298953

14 ML pertuzumab 30 MG/ML Injection [Perjeta] — RxCUI 1298953

RxNorm drug concept · Semantic branded drug
RxCUI 1298953 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1298953
Official name14 ML pertuzumab 30 MG/ML Injection [Perjeta]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPerjeta 420 MG per 14 ML Injection; Perjeta 420 MG in 14 ML Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)13,810 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pertuzumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Perjeta is a targeted therapy specifically designed for cancers that overexpress a protein called HER2. It works by attaching to the HER2 protein and blocking it from sending the g...
  • What exactly is Perjeta and why do I need it alongside other medicines?
  • Perjeta is given as an IV infusion by your care team in a clinic or infusion center — it goes directly into your vein through a drip. Each infusion takes between 30 and 60 minutes,...
  • How will I receive Perjeta, and how long does it take?
📖 Read our full Pertuzumab Injection guide →

🕸️ Concept Web — How 14 ML pertuzumab 30 MG/ML Injection [Perjeta] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 14 ML pertuzumab 30 MG/ML Injection [Perjeta] RxCUI 1298953

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pertuzumab 1298944
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Perjeta 1298949
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pertuzumab Injection 1657572
    • Pertuzumab Injectable Product 1298946
    • Pertuzumab Injection [Perjeta] 1657574
    • Perjeta Injectable Product 1298952
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Pertuzumab 30 MG/ML [Perjeta] SBDC · 1298950
  • Pertuzumab Injection [Perjeta] SBDF · 1657574
  • Perjeta Injectable Product SBDG · 1298952
  • Perjeta BN · 1298949

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1298953 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50242-0145-01 1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) / 14 mL in 1... PERJETA Genentech, Inc. 2012-06-08
Observed labelers: Genentech, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9306 Injection, pertuzumab, 1 mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.